Angelique Gougelet

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Hepatocyte expression of fetal insulin receptor isoform contributes to the promotion of liver cancer through non-cell autonomous mechanisms.

Hepatocyte expression of fetal insulin receptor isoform contributes to the promotion of liver cancer through non-cell autonomous mechanisms.

Journal: bioRxiv : the preprint server for biology

Published: June 12, 2025

NLRP6 deficiency enhances macrophage-mediated phagocytosis via E-Syt1 to inhibit hepatocellular carcinoma progression.

NLRP6 deficiency enhances macrophage-mediated phagocytosis via E-Syt1 to inhibit hepatocellular carcinoma progression.

Journal: Gut

Published: May 30, 2025

Rethinking the roles of oncogenes: How does oncoprotein loss worsen liver carcinogenesis?

Rethinking the roles of oncogenes: How does oncoprotein loss worsen liver carcinogenesis?

Journal: Hepatology (Baltimore, Md.)

Published: August 12, 2024

Wnt, glucocorticoid and cellular prion protein cooperate to drive a mesenchymal phenotype with poor prognosis in colon cancer.

Wnt, glucocorticoid and cellular prion protein cooperate to drive a mesenchymal phenotype with poor prognosis in colon cancer.

Journal: Journal of translational medicine

Published: February 12, 2024

Chromatin and DNA Dynamics in Mouse Models of Liver Cancers.

Chromatin and DNA Dynamics in Mouse Models of Liver Cancers.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: February 05, 2024

DLK1/DIO3 locus upregulation by a β-catenin-dependent enhancer drives cell proliferation and liver tumorigenesis.

DLK1/DIO3 locus upregulation by a β-catenin-dependent enhancer drives cell proliferation and liver tumorigenesis.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: December 01, 2023

Deleting the β-catenin degradation domain in mouse hepatocytes drives hepatocellular carcinoma or hepatoblastoma-like tumor growth.

Deleting the β-catenin degradation domain in mouse hepatocytes drives hepatocellular carcinoma or hepatoblastoma-like tumor growth.

Journal: Journal of hepatology

Published: July 01, 2021

Epigenetic mechanisms of liver tumor resistance to immunotherapy.

Epigenetic mechanisms of liver tumor resistance to immunotherapy.

Journal: World journal of hepatology

Published: February 23, 2021

Metabolic imaging assessing choline addiction in liver primary cancers predicts their oncogenotype and opens a new therapeutic avenue

Metabolic imaging assessing choline addiction in liver primary cancers predicts their oncogenotype and opens a new therapeutic avenue

Journal: Medecine sciences : M/S

Published: May 02, 2020

Expression of NKG2D ligands is downregulated by β-catenin signalling and associates with HCC aggressiveness.

Expression of NKG2D ligands is downregulated by β-catenin signalling and associates with HCC aggressiveness.

Journal: Journal of hepatology

Published: December 18, 2019

ARID1A loss in adult hepatocytes activates β-catenin-mediated erythropoietin transcription.

ARID1A loss in adult hepatocytes activates β-catenin-mediated erythropoietin transcription.

Journal: eLife

Published: November 12, 2019

Non-coding RNAs open a new chapter in liver cancer treatment.

Non-coding RNAs open a new chapter in liver cancer treatment.

Journal: Clinics and research in hepatology and gastroenterology

Published: June 06, 2019

Showing 1-12 of 25

Last Updated: 09/26/2026